General MedicationsTOPICALStandard
IVERMECTIN
IVERMECTIN
Standard Dose
1%
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview IVERMECTIN is listed in Drugs@FDA under application 215210 (ANDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient IVERMECTIN Form and strength CREAM;TOPICAL - 1% Sponsor ZYDUS LIFESCIENCES Submission history Latest submission status date: 2023-05-08 00:00:00.
Structured Monograph
Clinical summary
Approval overview IVERMECTIN is listed in Drugs@FDA under application 215210 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient IVERMECTIN Form and strength CREAM;TOPICAL - 1% Sponsor ZYDUS LIFESCIENCES Submission history Latest submission status date: 2023-05-08 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.